David Moatazedi - Net Worth and Insider Trading
David Moatazedi Net Worth
The estimated net worth of David Moatazedi is at least $8 Million dollars as of 2024-04-27. David Moatazedi is the See Remarks of Evolus Inc and owns about 689,614 shares of Evolus Inc (EOLS) stock worth over $8 Million. Details can be seen in David Moatazedi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Moatazedi has not made any transactions after 2024-03-27 and currently still holds the listed stock(s).
Transaction Summary of David Moatazedi
David Moatazedi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Moatazedi owns 4 companies in total, including Evolus Inc (EOLS) , Obalon Therapeutics Inc (OBLN) , and Reshape Lifesciences Inc (RSLS) among others .
Click here to see the complete history of David Moatazedi’s form 4 insider trades.
Insider Ownership Summary of David Moatazedi
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EOLS | Evolus Inc | 2024-03-27 | director & See Remarks |
| OBLN | Obalon Therapeutics Inc | 2019-07-23 | director |
| RSLS | Reshape Lifesciences Inc | 2017-03-13 | director |
| BMRA | Biomerica Inc | 2022-12-07 | director |
David Moatazedi Latest Holdings Summary
David Moatazedi currently owns a total of 1 stock. David Moatazedi owns 689,614 shares of Evolus Inc (EOLS) as of March 27, 2024, with a value of $8 Million.
Latest Holdings of David Moatazedi
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EOLS | Evolus Inc | 2024-03-27 | 689,614 | 11.43 | 7,882,288 |
Holding Weightings of David Moatazedi
David Moatazedi Form 4 Trading Tracker
According to the SEC Form 4 filings, David Moatazedi has made a total of 14 transactions in Evolus Inc (EOLS) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Evolus Inc is the sale of 6,236 shares on March 27, 2024, which brought David Moatazedi around $86,431.
Insider Trading History of David Moatazedi
- 1
David Moatazedi Trading Performance
David Moatazedi Ownership Network
Ownership Network List of David Moatazedi
Ownership Network Relation of David Moatazedi
David Moatazedi Owned Company Details
What does Evolus Inc do?
Who are the key executives at Evolus Inc?
David Moatazedi is the director & See Remarks of Evolus Inc. Other key executives at Evolus Inc include See Remarks Rui Avelar , Chief Financial Officer Sandra Beaver , and 10 percent owner Medytox Inc. .
Evolus Inc (EOLS) Insider Trades Summary
Over the past 18 months, David Moatazedi made 7 insider transaction in Evolus Inc (EOLS) with a net sale of 278,255. Other recent insider transactions involving Evolus Inc (EOLS) include a net sale of 6,102,728 shares made by Medytox Inc. , a net sale of 46,541 shares made by Rui Avelar , and a net sale of 12,882 shares made by Sandra Beaver .
In summary, during the past 3 months, insiders sold 159,356 shares of Evolus Inc (EOLS) in total and bought 0 shares, with a net sale of 159,356 shares. During the past 18 months, 8,302,337 shares of Evolus Inc (EOLS) were sold and 174,967 shares were bought by its insiders, resulting in a net sale of 8,127,370 shares.
Evolus Inc (EOLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Evolus Inc Insider Transactions
David Moatazedi Mailing Address
Above is the net worth, insider trading, and ownership report for David Moatazedi. You might contact David Moatazedi via mailing address: C/o Obalon Therapeutics, Inc., 5421 Avenida Encinas, Suite F, Carlsbad Ca 92008.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
